Accessed June 24, 2020
Trial evidence: Tesamorelin 2mg SC daily sustained GH/IGF-1 elevation, 15-18% visceral fat reduction over 6 months (Falutz, NEJM 2007, PMID 17699044) Ipamorelin 200-300 mcg peak GH 5-10x baseline within 30 minutes, no cortisol/prolactin bump (Raun, EJE 1998, PMID 9539826) GHRH + GHRP synergy 2-3x greater amplitude than either alone (Bowers, JCEM 1991, PMID 2004615) Community protocols extend this evidence base with cycling patterns that weren't studied in the original trials the 5-on/2-off rhythm and 8-week cycles are empirical community consensus, not clinically validated
This decrease can be accelerated by poor lifestyle choices like an unhealthy diet, inactivity, or toxin exposure contributing to increased oxidative stress linked with age-related conditions
Skin Health, Tone, and Age-Related Changes Injectable glutathione has gained considerable attention in aesthetic medicine circles for its potential effects on skin appearance
Female reproductive tissue is responsive to cyclic hormones, estrogen and progesterone, and BPC-157s promotion of angiogenesis and decreased local inflammation could alter follicle microenvironment and endometrial lining quality
